These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8197765)

  • 21. Progress in systemic adjuvant therapy of early-stage breast cancer.
    Gradishar WJ; O'Regan RM
    Int J Clin Oncol; 2003 Aug; 8(4):239-47. PubMed ID: 12955580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
    Tormey DC; Gray R; Falkson HC
    J Natl Cancer Inst; 1996 Dec; 88(24):1828-33. PubMed ID: 8961972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical management of early-stage breast cancer.
    Bookman MA; Goldstein LJ; Scher RM
    Curr Probl Cancer; 1991; 15(4):157-232. PubMed ID: 1874006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
    Gelber RD; Cole BF; Goldhirsch A; Rose C; Fisher B; Osborne CK; Boccardo F; Gray R; Gordon NH; Bengtsson NO; Sevelda P
    Lancet; 1996 Apr; 347(9008):1066-71. PubMed ID: 8602056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary chemotherapy in breast cancer.
    Smith IE; al-Moundhri M
    Biomed Pharmacother; 1998; 52(3):116-21. PubMed ID: 9755804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
    Cadoo KA; Morris PG; Cowell EP; Patil S; Hudis CA; McArthur HL
    Clin Breast Cancer; 2016 Dec; 16(6):487-493. PubMed ID: 27622751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy for breast cancer patients with negative lymph nodes.
    Friedman MA; Dorr FA; Perloff M
    NCI Monogr; 1986; (1):139-44. PubMed ID: 3534587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic therapy in resectable breast cancer.
    Bonadonna G; Valagussa P
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):727-42. PubMed ID: 2691496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.
    Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y
    Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status.
    Muss HB
    J Natl Cancer Inst Monogr; 2001; (30):52-5. PubMed ID: 11773292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant systemic therapy: state of the art, 1989.
    Henderson IC
    Breast Cancer Res Treat; 1989 Oct; 14(1):3-22. PubMed ID: 2690970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effectiveness of adjuvant therapy for patients with early-stage (I-IIa) breast cancer].
    Semiglazov VF
    Vopr Onkol; 1998; 44(2):137-41. PubMed ID: 9615814
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant chemotherapy of breast cancer--the Consensus Development Conference revisited.
    Abeloff MD; Beveridge RA
    Oncology (Williston Park); 1988 Apr; 2(4):21-6, 29-33. PubMed ID: 3079325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy in the management of breast cancer.
    Overmoyer BA
    Cleve Clin J Med; 1995; 62(1):36-50. PubMed ID: 7859401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy for all patients with breast cancer?
    Lippman ME; Hayes DF
    J Natl Cancer Inst; 2001 Jan; 93(2):80-2. PubMed ID: 11208870
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current status of adjuvant chemotherapy for breast cancer].
    Takeuchi H; Okubo K; Fujiuchi N; Saeki T
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):736-41. PubMed ID: 16770090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab: clinicopathological features, efficacy, and factors affecting survival.
    Ulas A; Kos T; Avci N; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    Asian Pac J Cancer Prev; 2015; 16(4):1643-9. PubMed ID: 25743846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.